Managing Illnesses
-
s Sponsored
How to Optimize the $1 Billion Investment in a Rare Drug Strategy
An effective rare disease drug strategy for Canada will require infrastructure and research investments, alternative managed access pathways, and more. In 2019, the federal government committed $1 billion to invest in a rare disease drug strategy with an ongoing investment of $500 million annually. Following three years of nationwide multi-stakeholder consultations, the Canadian Organization for...
-
Science Brings Hope to Canadians
Incyte believes that every challenge is the chance for a breakthrough Incyte is a global biopharmaceutical company on a mission to discover, develop and bring best-in-class medical advances to people suffering from diseases with limited options. The company was founded on the premise that investment in strong science and the relentless pursuit of R&D excellence...
-
Heart Disease and T2D Are Linked — And Proper Care Is Key
Weldon Wadden and his daughter, Nancy Wadden
-
Controlling Eczema Ensures People Feel Good in their Skin — Inside and Out
Signs and symptoms of eczema vary across a diversity of skin tones and pigmentations. Recognizing them is important to ensure proper treatment.
-
Ease Burden of Psoriasis with Treatment Options and Support
Psoriasis is more than skin deep. Understanding its impact helps to manage symptoms. Psoriasis is a chronic inflammatory skin disease that is estimated to affect up to one million Canadians and about 125 million people worldwide. 1,2 “Psoriasis, in its most common form known as ‘chronic plaque psoriasis,’ is characterized by skin scaling and flaking,...
-
Support and Effective Treatment Options for People with Atopic Dermatitis
With vast information resources and effective treatment options, people with eczema no longer need to suffer in silence. Atopic dermatitis (AD) is a chronic, inflammatory skin condition that’s related to eczema. Symptoms include intense itching, dry scaly skin, and a rash on the face, hands, arms, legs, and other parts of the body.1 People living with...
-
A Growing Epidemic — Diabetes Isn’t Slowing Down, and We Can’t Either
Inching forward, the new diabetes framework instills hope in millions of Canadians affected by the disease. With 640 new cases daily, 26 hourly, or one every three minutes — diabetes isn’t slowing down. In fact, today, there are 11.7 million people in Canada living with diabetes or prediabetes, which is expected to increase by 19...
-
s Sponsored
A Framework to Help End the Effects of Diabetes in Canada
Canada is moving forward with a national plan of action to support people affected by diabetes. For the past five years, Diabetes Canada, in collaboration with more than 100 stakeholders across the country, has been leading the charge for a diabetes strategy and framework to address the diabetes epidemic, impacting one in three Canadians and...
-
Improving How We Prevent, Diagnose, and Treat Diabetic Retinopathy
People living with diabetes, physicians, patient advocates, and policymakers must work together to prevent, diagnose, and treat diabetic retinopathy. People living with diabetes have an elevated risk of eye disease. High blood sugar levels can damage the small blood vessels in the retina, leading to conditions such as diabetic retinopathy. While diabetic retinopathy can initially...
-
s Sponsored
Collaborating to Optimize Diabetes Care and Treatment in Canada
As a leader in diabetes research globally, Canada is home to many of the latest resources, education, and services to help people better manage their diabetes. Every year, more than 1,800 diabetes health-care providers gather at the Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference to share their latest discoveries and collaborate on...
Health Insight